Sirolimus
NDC 16571-806, Sirolimus, solution, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-806
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215116
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-806 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SIROLIMUS1 mg/mL
Pharmacologic classes
Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-806-06 | 16571080606 | 1 CARTON in 1 KIT (16571-806-06) / 1 BOTTLE, GLASS in 1 CARTON / 60 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/400da0a5-2a85-44ab-a2c5-bb9161750db3NADAC price for package 16571080606
GET /v1/drugs/nadac/16571080606
Use it
Look up 16571-806 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-806 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-806. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.